-
News | 2022.02.16
COVID-19: reducing outbreak risk with repeated antigen screening in healthcare facilities
With the emergence of the Omicron variant, healthcare facilities remain highly vulnerable to virus spread. Effective surveillance of viral presence in these facilities is therefore crucial and needs to be adapted according to outbreak risk. Scientists from the Institut Pasteur worked with colleagues to analyze the reactive use of antigen testing in a long-term care facility following a detected...
-
News | 2024.05.30
Escherichia coli bacteria establish antibiotic resistance via a defense mechanism
A defense system has been discovered in Escherichia coli bacteria by Institut Pasteur scientists. In this system, the bacteria eliminate a small DNA molecule (the plasmid) known to carry antibiotic resistance genes, but not before the resistance genes have been integrated into the bacterial chromosome. In defending themselves, the bacteria establish antibiotic resistance. This discovery is a...
-
News | 2025.01.17
Listeria virulence: the key role of gene expression
The bacterium Listeria monocytogenes can be pathogenic to humans and cause listeriosis, a potentially fatal infection. Until now, the variability in the pathogenicity of Listeria monocytogenes was not clearly understood. But a team from the Institut Pasteur has recently shed new light on a new mechanism that determines virulence by regulating gene expression.
-
Article | 2016.12.20
Cité Internationale Universitaire de Paris
A partnership with the Cité Internationale Universitaire de Paris (CIUP) has been renewed, providing the Institut Pasteur with 65 housing units.
-
Article | 2025.09.05
Housing: FAQ (frequently asked questions)
Frequently asked questions about accommodation offered by the Institut Pasteur
-
Portrait | 2020.01.30
Jean-Philippe Chippaux – bitten by the snake bug
Jean-Philippe Chippaux is a hands-on guy. Throughout his career, he has contributed to the prevention and treatment of several neglected tropical diseases in a number of countries in Africa and Latin America. Alongside this work for the French Research Institute for Development (IRD), he has devoted his attention over the past four decades to studying snakes and snake bites. Although his...
-
News | 2020.07.20
i-Lab 2020 competition: two winners from the Institut Pasteur, one awarded a Grand Prix
On July 16, the i-Lab 2020 innovation competition unveiled the names of 73 winners, which this year included the D4Zin (Grand Prix) and AVATAR MEDICAL projects, both based on research carried out at the Institut Pasteur and supported by the Pasteur Microbes and Health Carnot Institute.Sponsored by the French Ministry of Higher Education, Research and Innovation and organized in partnership with...
-
Portrait | 2023.06.12
Camille Berthelot, the Indiana Jones of endometriosis
Painful periods, menstruation, endometriosis, diagnostic odyssey – Camille Berthelot is not afraid to delve into topics that are sometimes seen as taboo but affect a large part of the world's population. She specializes in comparative genomics of species and leads her own group at the Institut Pasteur. She and her team are currently working to find a biological marker that could be used for early...
-
Portrait | 2023.10.02
Javier Pizarro-Cerda : science, plague and rock'n roll!
Javier Pizarro-Cerda's upbringing gave him curiosity, an interest in biology and science, as well as a lifelong passion for music! After his studies in Costa Rica, he came to Europe to become a scientist.Today at the Institut Pasteur in Paris, his research on plague and other Yersinia infections follows on from the work of his predecessors and also explores the history of deadly epidemics of the...
-
Portrait | 2023.02.10
Caroline Demangel – an ambitious and enterprising scientist
Finding her path, making meaningful choices and daring to take the initiative – these are the principles that have guided Caroline Demangel through her career. In the demanding and competitive field of science, she has trusted her aspirations and risen to new challenges. In 2021, the scientist and her team revealed a new therapeutic target for bone marrow cancer.